Safety and preliminary signs of efficacy with the combination of pembrolizumab plus oxaliplatin and S-1 in Japanese gastric cancer patients
Date
2020-12Permanent link
https://hdl.handle.net/11351/6430DOI
10.21037/atm-20-4725
ISSN
2305-5847
WOS
000612339500010
PMID
33490208
Keywords
Gastric cancer; Efficacy; PembrolizumabBibliographic citation
Alsina M, Smyth EC. Safety and preliminary signs of efficacy with the combination of pembrolizumab plus oxaliplatin and S-1 in Japanese gastric cancer patients. Ann Transl Med. 2020 Dec;8(24):1696.
Audience
Professionals
This item appears in following collections
- HVH - Articles científics [4476]
- VHIO - Articles científics [1250]
The following license files are associated with this item:




